These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12658930

  • 41. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I, Choudhury A, Patel J, Lip GY.
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [Abstract] [Full Text] [Related]

  • 42. [Measurement of plasma malondialdehyde contents and erythrocyte superoxide dismutase activities in patients with chronic cor pulmonale].
    Cheng P.
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Oct; 14(5):271-2, 318. PubMed ID: 1819377
    [Abstract] [Full Text] [Related]

  • 43. The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.
    Gong K, Zhang Z, Sun X, Zhang X, Li A, Yan J, Luo Q, Gao Y, Feng Y.
    Am Heart J; 2006 Jan; 151(1):62-8. PubMed ID: 16368293
    [Abstract] [Full Text] [Related]

  • 44. [Observation on the content of plasma lipoperoxide and serum superoxide dismutase in NIDDM nephrosis patients].
    Chen X, Liu H, Yi M.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):305-8. PubMed ID: 10453573
    [Abstract] [Full Text] [Related]

  • 45. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
    Cera M, Salerno A, Fragasso G, Montanaro C, Gardini C, Marinosci G, Arioli F, Spoladore R, Facchini A, Godino C, Margonato A.
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):24-30. PubMed ID: 20100903
    [Abstract] [Full Text] [Related]

  • 46. [Clinical study of changes of urotensin II in patients with congestive heart failure].
    Zhong P, Li ZL, Wu HC, Tang CS, Lu Q.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):121-3. PubMed ID: 12581957
    [Abstract] [Full Text] [Related]

  • 47. Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover?
    Tabbi-Anneni I, Helies-Toussaint C, Morin D, Bescond-Jacquet A, Lucien A, Grynberg A.
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1003-9. PubMed ID: 12604675
    [Abstract] [Full Text] [Related]

  • 48. Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure.
    Thrainsdottir IS, von Bibra H, Malmberg K, Rydén L.
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):101-8. PubMed ID: 15175564
    [Abstract] [Full Text] [Related]

  • 49. [Effect of atenolol and trimetazidine on dispersion of cardiac rhythm in patients with moderately expressed postinfarction left ventricular dysfunction].
    Kaliuzhin VV, Tepliakov AT, Kamaev DIu, Solovtsov MA.
    Ter Arkh; 2002 Jul; 74(8):42-4. PubMed ID: 12360593
    [Abstract] [Full Text] [Related]

  • 50. [Effects of trimetazidine therapy on left ventricular function after percutaneous coronary intervention].
    Xu XH, Zhang WJ, Zhou YJ, Zhou ZM, Ma HY, Hu B, Kang YP, Luo FF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):205-9. PubMed ID: 23879944
    [Abstract] [Full Text] [Related]

  • 51. [Possibilities of myocardial cytoprotection in complex treatment of patients with chronic heart failure].
    Vasiuk IuA, Iushchuk EN, Shkol'nik EL, Khadzegova AB, Vit'ko NK, Vakhromeeva MN.
    Kardiologiia; 2006 Mar; 46(11):48-56. PubMed ID: 17159882
    [Abstract] [Full Text] [Related]

  • 52. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.
    Fragasso G, Rosano G, Baek SH, Sisakian H, Di Napoli P, Alberti L, Calori G, Kang SM, Sahakyan L, Sanosyan A, Vitale C, Marazzi G, Margonato A, Belardinelli R.
    Int J Cardiol; 2013 Mar 10; 163(3):320-325. PubMed ID: 23073279
    [Abstract] [Full Text] [Related]

  • 53. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Gao D, Ning N, Niu X, Hao G, Meng Z.
    Heart; 2011 Feb 10; 97(4):278-86. PubMed ID: 21134903
    [Abstract] [Full Text] [Related]

  • 54. Is treatment with trimetazidine beneficial in patients with chronic heart failure?
    Zhou X, Chen J.
    PLoS One; 2014 Feb 10; 9(5):e94660. PubMed ID: 24797235
    [Abstract] [Full Text] [Related]

  • 55. [Efficacy of prostaglandin E1 in treatment of cor pulmonale patients with heart failure].
    Zhou SC, Wang W, Hu Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr 10; 20(2):88-90. PubMed ID: 10072831
    [Abstract] [Full Text] [Related]

  • 56. [Changes and clinical significance of serum level of syndecan-4 protein in patients with chronic congestive heart failure].
    Ma X, Ouyang P, Zhang Z, Lai W, Xu D.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug 10; 29(8):866-9. PubMed ID: 23948417
    [Abstract] [Full Text] [Related]

  • 57. [The change of filtration-index of erythrocyte malonyldialdehyde and superoxide dismutase in patients with pregnancy induced hypertension].
    Du D, Wang W, Luo G.
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov 10; 30(11):662-4. PubMed ID: 8745490
    [Abstract] [Full Text] [Related]

  • 58. [Oxygen dependent metabolism of neutrophils and monocytes in patients with unstable angina and its correction with preductal].
    Romanov VA, Kratnov AE, Romanova NV, Khrustalev OA.
    Patol Fiziol Eksp Ter; 2002 Nov 10; (2):15-7. PubMed ID: 12152422
    [Abstract] [Full Text] [Related]

  • 59. [Effect of probucol on serum malondialdehyde and superoxide dismutase in patients with primary hypertension].
    Rong H, Tan M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May 10; 37(5):458-62. PubMed ID: 22659656
    [Abstract] [Full Text] [Related]

  • 60. The effects of trimetazidine on heart rate variability in patients with heart failure.
    Gunes Y, Guntekin U, Tuncer M, Sahin M.
    Arq Bras Cardiol; 2009 Aug 10; 93(2):154-8. PubMed ID: 19838493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.